Grants and Contracts Details
| Status | Finished |
|---|---|
| Effective start/end date | 4/25/22 → 2/19/26 |
Funding
- Woolsey Pharmaceuticals Incorporated: $172,007.00
WP-0512-003: A Phase 2a Open-Label Preliminary Safety, Efficacy, and Biomarker Study of WP-0512 in Patients with Amyotrophic Lateral Sclerosis (ALS)
- Sun, Yuyao (PI)
- Kasarskis, Edward (CoI)
- Mathur Kumaraswamy, Vishakhadatta (Former PI)